LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

Home・Listă Acțiuni・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Închisă

SectorSănătate

33.95 -5.14

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

32.81

Maxim

35.12

Indicatori cheie
By Trading Economics
Venit	-5.8M 40M
Vânzări	16M 200M
P/E Medie Sector	11.9 35.733
EPS	0.92
Marjă de profit	19.839
Angajați	268
EBITDA	3M 59M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+41.86% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 oct. 2025

Statistici piață
By TradingEconomics
Capitalizare de piață	82M 2.1B
Deschiderea anterioară	39.09
Închiderea anterioară	33.95

Sentimentul știrilor

By Acuity

100%

147 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

29.8 / N/A Suport & Rezistență

Harmony Biosciences Holdings Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 sept. 2025, 23:37 UTC

Acțiuni populare

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 sept. 2025, 20:41 UTC

Câștiguri

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 sept. 2025, 20:30 UTC

Câștiguri

GameStop 2Q Sales, Profit Rise

9 sept. 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 sept. 2025, 21:35 UTC

Câștiguri

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 21:32 UTC

Câștiguri

Oracle's Backlog Swells With Big Customer Deals -- Update

9 sept. 2025, 21:02 UTC

Achiziții, Fuziuni, Preluări

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 sept. 2025, 20:33 UTC

Câștiguri

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 sept. 2025, 20:26 UTC

Câștiguri

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:23 UTC

Câștiguri

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:12 UTC

Câștiguri

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 sept. 2025, 20:10 UTC

Câștiguri

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 sept. 2025, 20:10 UTC

Câștiguri

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 sept. 2025, 20:09 UTC

Câștiguri

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 sept. 2025, 20:09 UTC

Câștiguri

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 sept. 2025, 20:08 UTC

Câștiguri

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 sept. 2025, 20:07 UTC

Câștiguri

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 sept. 2025, 20:06 UTC

Câștiguri

Oracle 1Q Software Revenue $5.72B >ORCL

9 sept. 2025, 20:06 UTC

Câștiguri

Synopsys 3Q Adj EPS $3.39 >SNPS

9 sept. 2025, 20:06 UTC

Câștiguri

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Rev $14.93B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q EPS $1.01 >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Synopsys 3Q EPS $1.50 >SNPS

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Services Revenue $1.35B >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Adj EPS $1.47 >ORCL

9 sept. 2025, 20:05 UTC

Câștiguri

Oracle 1Q Hardware Revenue $670M >ORCL

Comparație

Modificare preț

Harmony Biosciences Holdings Inc Așteptări

Obiectiv de preț

By TipRanks

41.86% sus

Prognoză pe 12 luni

Medie 50.83 USD 41.86%

Maxim 70 USD

Minim 33 USD

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHarmony Biosciences Holdings Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

7 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 7 analiști care au acordat evaluări ale acțiunilor Harmony Biosciences Holdings Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

29.8 / N/ASuport & Rezistență

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

147 / 371 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.